End Price Gouging for Medications Act

The End Price Gouging for Medications Act would require the federal government to cap the cost of prescription drugs in the United States based on the average prices paid in other major developed nations. Under this bill, pharmaceutical companies would be prohibited from charging American patients, including those with private insurance or no insurance at all, more than the established international reference price. If passed, the legislation aims to lower out-of-pocket costs for consumers by ensuring that medication prices in the U.S. are consistent with those in countries like Canada, France, and Germany.